Evidence map›Paper›PMID 28266626›Full record

ArticleScientific reports2017

Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity.

Wenwen Gu, Wenping Xu, Xiaoxi Sun, Bubing Zeng, Shuangjie Wang, Nian Dong, Xu Zhang, Chengshui Chen, Long Yang, Guowu Chen and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Wenwen GuKey Laboratory of Contraception Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai, 200032, China.
Wenping XuShanghai Key Laboratory of Chemical Biology, School of Pharmacy, East-China University of Science, and Technology, 130 Meilong Road, Shanghai, 200237, China.
Xiaoxi SunObstetrics and Gynecology Hospital, Shanghai Ji Ai Genetics and IVF Institute, Institute of Reproduction and Development, Fudan University, Shanghai, 200011, China.
Bubing ZengShanghai Key Laboratory of Chemical Biology, School of Pharmacy, East-China University of Science, and Technology, 130 Meilong Road, Shanghai, 200237, China.
Shuangjie WangKey Laboratory of Contraception Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai, 200032, China.
Nian DongThe First Affiliated Hospital, Department of Pulmonary Medicine, Chen, Wenzhou city, zhejiang Province, China.
Xu ZhangKey Laboratory of Contraception Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai, 200032, China.
Chengshui ChenThe First Affiliated Hospital, Department of Pulmonary Medicine, Chen, Wenzhou city, zhejiang Province, China.
Long YangNew Drug Research and Development Center, School of Pharmacy, Second Military Medical University, Shanghai, China.
Guowu ChenObstetrics and Gynecology Hospital, Shanghai Ji Ai Genetics and IVF Institute, Institute of Reproduction and Development, Fudan University, Shanghai, 200011, China.
Aijie XinObstetrics and Gynecology Hospital, Shanghai Ji Ai Genetics and IVF Institute, Institute of Reproduction and Development, Fudan University, Shanghai, 200011, China.
Zhong NiInstitute of Life Sciences, Jiangsu University, Zhenjiang 212013, China.
Jian WangKey Laboratory of Contraception Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai, 200032, China.
Jun YangKey Laboratory of Contraception Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai, 200032, China.
Fudan University · CNShanghai Institute of Planned Parenthood Research · CNEast China University of Science and Technology · CNShangHai JiAi Genetics & IVF Institute · CNFirst Affiliated Hospital of Wenzhou Medical University · CNJiangsu University · CNSecond Military Medical University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tamoxifen is administered for estrogen receptor positive (ER

Indexed as

AnimalsAntineoplastic Agents, HormonalCell Line, TumorContraceptives, Oral, SyntheticEndometrial NeoplasmsFemaleHeterograftsHumansMice, Inbred ICRMice, NudeNeoplasm TransplantationNon-alcoholic Fatty Liver DiseaseNorandrostanesTamoxifenTreatment OutcomeanordrinAntineoplastic Agents, HormonalContraceptives, Oral, SyntheticNorandrostanesTamoxifen

Identifiers

PMID28266626
PMCPMC5339706
OpenAlexW2591988979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.